Exchange: NASDAQ·Updated 07:48 AM EDT

ASND News

News
all
press releases
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset
BMRN turns a competitive threat into a royalty stream as Ascendis pays royalties on Yuviwel sales, reshaping the economics of competition.
Zacks
More News
ASND, BMRN Stocks Rise: Street Calls Patent Peace A Clean Overhang Lift, Keep Ratings Unchanged
BioMarin and Ascendis settled a global patent dispute over the achondroplasia drug Yuviwel on Sunday.
Stocktwits
Ascendis Pharma, Science Applications International And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday. Shares of Ascendis Pharma A/S (NASDAQ:ASND) rose sharply on Monday. On Sunday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)read more...
Benzinga
FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo
BioMarin's FDA filing for full Voxzogo approval in achondroplasia has been accepted, with a regulatory decision expected by Feb. 28, 2027.
Zacks
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
BBIO builds on Attruby's launch as rising rare disease diagnoses and late-stage pipeline candidates set up multiple potential U.S. launches.
Zacks
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Pharma's Attruby sales are surging, but can growth keep justifying its premium valuation amid execution risks and rising costs?
Zacks
Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?
Ascendis Pharma (ASND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia
BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, supporting planned FDA filings in 2026.
Zacks
Growth Stocks To Keep An Eye On - May 6th
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Pershing Square, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster...
MarketBeat
Morse Asset Management Inc Purchases Shares of 6,489 Ascendis Pharma A/S $ASND
Morse Asset Management Inc purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat

Advertisement|Remove ads.